| A clinically applicable molecular-based classification for endometrial cancers A Talhouk, MK McConechy, S Leung, HH Li-Chang, JS Kwon, N Melnyk, ... British journal of cancer 113 (2), 299-310, 2015 | 741 | 2015 |
| Confirmation of ProMisE: a simple, genomics‐based clinical classifier for endometrial cancer A Talhouk, MK McConechy, S Leung, W Yang, A Lum, J Senz, N Boyd, ... Cancer 123 (5), 802-813, 2017 | 702 | 2017 |
| Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience E Hansch, U Chitkara, J McAlpine, Y El-Sayed, MD Dake, MK Razavi American journal of obstetrics and gynecology 180 (6), 1454-1460, 1999 | 525 | 1999 |
| Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series S Kommoss, MK McConechy, F Kommoss, S Leung, A Bunz, J Magrill, ... Annals of Oncology 29 (5), 1180-1188, 2018 | 523 | 2018 |
| Distinct evolutionary trajectories of primary high‐grade serous ovarian cancers revealed through spatial mutational profiling A Bashashati, G Ha, A Tone, J Ding, LM Prentice, A Roth, J Rosner, ... The Journal of pathology 231 (1), 21-34, 2013 | 489 | 2013 |
| Endometrial cancer EJ Crosbie, SJ Kitson, JN McAlpine, A Mukhopadhyay, ME Powell, ... The Lancet 399 (10333), 1412-1428, 2022 | 424 | 2022 |
| TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data G Ha, A Roth, J Khattra, J Ho, D Yap, LM Prentice, N Melnyk, ... Genome research 24 (11), 1881-1893, 2014 | 392 | 2014 |
| Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017 | 391 | 2017 |
| Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer A McPherson, A Roth, E Laks, T Masud, A Bashashati, AW Zhang, G Ha, ... Nature genetics 48 (7), 758-767, 2016 | 340 | 2016 |
| Use of mutation profiles to refine the classification of endometrial carcinomas MK McConechy, J Ding, MCU Cheang, KC Wiegand, J Senz, AA Tone, ... The Journal of pathology 228 (1), 20-30, 2012 | 333 | 2012 |
| A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer LA Brotto, Y Erskine, M Carey, T Ehlen, S Finlayson, M Heywood, J Kwon, ... Gynecologic oncology 125 (2), 320-325, 2012 | 325 | 2012 |
| Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention JN McAlpine, GE Hanley, MMM Woo, AA Tone, N Rozenberg, ... American journal of obstetrics and gynecology 210 (5), 471. e1-471. e11, 2014 | 299 | 2014 |
| Interfaces of malignant and immunologic clonal dynamics in ovarian cancer AW Zhang, A McPherson, K Milne, DR Kroeger, PT Hamilton, A Miranda, ... Cell 173 (7), 1755-1769. e22, 2018 | 298 | 2018 |
| Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles MK McConechy, J Ding, J Senz, W Yang, N Melnyk, AA Tone, LM Prentice, ... Modern pathology 27 (1), 128-134, 2014 | 288 | 2014 |
| Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling AW Zhang, C O’Flanagan, EA Chavez, JLP Lim, N Ceglia, A McPherson, ... Nature methods 16 (10), 1007-1015, 2019 | 271 | 2019 |
| Molecular classification of grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups T Bosse, RA Nout, JN McAlpine, MK McConechy, H Britton, YR Hussein, ... The American journal of surgical pathology 42 (5), 561-568, 2018 | 270 | 2018 |
| Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes YK Wang, A Bashashati, MS Anglesio, DR Cochrane, DS Grewal, G Ha, ... Nature genetics 49 (6), 856-865, 2017 | 251 | 2017 |
| 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma CH Lee, WB Ou, A Mariño-Enriquez, M Zhu, M Mayeda, Y Wang, X Guo, ... Proceedings of the National Academy of Sciences 109 (3), 929-934, 2012 | 250 | 2012 |
| Clinicopathological and molecular characterisation of ‘multiple‐classifier’endometrial carcinomas A León‐Castillo, E Gilvazquez, R Nout, VT Smit, JN McAlpine, ... The Journal of pathology 250 (3), 312-322, 2020 | 247 | 2020 |
| Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease JY Hou, MG Kelly, H Yu, JN McAlpine, M Azodi, TJ Rutherford, ... Gynecologic oncology 105 (1), 211-217, 2007 | 247 | 2007 |
